Literature DB >> 30087903

A Case of Bilateral Nocardia francinia Adrenal Abscesses in an Intravenous Drug-Using Splenectomized Patient With Tricuspid Endocarditis.

Lesley E Jackson1, Mahmoud Shorman2.   

Abstract

Adrenal abscesses due to disseminated nocardiosis are exceedingly rare in clinical practice, and to date only 8 cases have been reported in the literature, most of which were confined to a single adrenal gland. These infections often occur in patients with underlying immune deficiency. We report a rare case of bilateral nocardial adrenal abscesses in an intravenous drug-using splenectomized patient that presumably originated from direct inoculation using intravenous opana, as his admission chest radiograph was normal.

Entities:  

Keywords:  abscess; adrenal gland; disseminated nocardiosis; splenectomy

Year:  2018        PMID: 30087903      PMCID: PMC6061691          DOI: 10.1093/ofid/ofy141

Source DB:  PubMed          Journal:  Open Forum Infect Dis        ISSN: 2328-8957            Impact factor:   3.835


CASE PRESENTATION

A 39-year-old male smoker with history of remote surgical splenectomy following traumatic splenic laceration and active intravenous drug use (IVDU) with oxymorphone presented with complaints of fever, generalized weakness, abdominal pain, and orthostatic symptoms of 7 days’ duration. Physical exam was remarkable for cachexia, with a body mass index (BMI) of 18 kg/m2, dehydration, and abdominal tenderness. Admission labs were significant for creatinine of 2.23 mg/dL, profound leukocytosis (white blood cell count of 43 000 cells/mcL with 84.5% neutrophils), thrombocytosis (602 000 platelets/mcL), and elevated procalcitonin at 1.81 ng/mL. Computed tomography (CT) of the abdomen and pelvis noted the presence of bilateral multiloculated rim-enhancing regions within both adrenal glands (Figures 1 and 2). HIV testing was negative, and hepatitis C antibody was positive. The patient was initially started on meropenem 500 mg intravenous (IV) every 6 hours and IV vancomycin; admission chest radiograph (CXR) was read as unremarkable, and transthoracic echo showed a small vegetation on the tricuspid valve. Interventional radiology placed bilateral percutaneous drains in the adrenal glands.
Figure 1.

A computerized axial tomography scan of the abdomen showing an 8.1 × 5.1-cm left adrenal mass and an 8.3 × 4.9-cm right adrenal mass.

Figure 2.

A computerized tomography scan in coronal view showing abscesses in the bilateral adrenal glands.

A computerized axial tomography scan of the abdomen showing an 8.1 × 5.1-cm left adrenal mass and an 8.3 × 4.9-cm right adrenal mass. A computerized tomography scan in coronal view showing abscesses in the bilateral adrenal glands. Admission blood cultures grew branching gram-positive rods, which were confirmed to be Nocardia francinia in 2 out of 2 samples obtained after 24 days of incubation. The organism was ultimately speciated at the state lab. Susceptibility testing was not done as it was not initially included in the request by microbiology. The patient was clinically improving, so it was not pursued. Multiple cultures from the percutaneous drains also grew Nocardia francinia. Antibiotics were modified to IV trimethoprim-sulfamethoxazole (TMP-SMX) in appropriate doses, and IV meropenem was continued. The patient ultimately completed 4 weeks of combination meropenem and TMP-SMX, with clinical and radiographic improvement and weight gain of 25 kg, and the patient was transitioned to oral maintenance therapy with TMP-SMX with plans to continue for 12 months and discharged home. Unfortunately, the patient was lost to follow-up.

DISCUSSION

Nocardia bacteria are soil-dwelling, gram-positive rods that are weakly acid-fast and are found ubiquitously in the environment [1, 2]. Disseminated disease occurs more commonly in patients with predisposing immunocompromising disease; however, cases have occurred in patients even in the absence of any predisposing risk factor. It has a high mortality, especially when the central nervous system is involved [1-4]. As the prevalence of immunocompromised patients has increased in recent decades due to advances in treatments for autoimmune disease and malignancy, so too has the incidence of invasive nocardiosis [1]. Our patient’s risk factors for nocardiosis included his prior splenectomy, malnutrition, and active IVDU status. Splenectomy as a risk factor had occasionally been described in prior case reports; however, most of these patients had other underlying immunocompromising conditions or therapies [5-7]. Characteristics of the previously reported cases of nocardiosis in splenectomized patients are outlined in Table 1.
Table 1.

Prior Cases of Disseminated Nocardiosis in Adult Splenectomized Patients

No.ReferenceAge, y/SexPredisposing factorReason for splenectomyNocardia Organ Involvement Nocardia spp.Final Antibiotics UsedOutcome
1Abdi et al.43/maleLymphocytic lymphomaSplenomegaly and pancytopeniaPulmonary Asteroides Co-trimoxazoleDied
2Abdi et al.29/femaleHodkins lymphomaSplenomegalyPulmonary Asteroides Co-trimoxazoleSurvived
3Abdi et al.44/maleNodular lymphomaSplenomegaly and pancytopeniaPulmonary Asteroides Co-trimoxazoleSurvived
4Casas Vara et al.32/maleAlcohol abuseRoad traffic accidentPulmonary Not speciated Co-trimoxazoleSurvived
5Moitra et al.29/femaleSLEThrombocytopeniaCNS Asteroides LinezolidSurvived
6This case39/maleMalnutrition, IVDUTraumatic splenic lacerationBacteremia, adrenal gland Francinia Merepenem and TMP-SMXSurvived

Abbreviations: CNS, central nervous system; IVDU, intravenous drug user; SLE, systemic lupus erythematosus; TMP-SMX, trimethoprim-sulfamethoxazole.

Prior Cases of Disseminated Nocardiosis in Adult Splenectomized Patients Abbreviations: CNS, central nervous system; IVDU, intravenous drug user; SLE, systemic lupus erythematosus; TMP-SMX, trimethoprim-sulfamethoxazole. The majority of nocardiosis infections in the United States manifest as pulmonary nocardiosis, whereas bacteremia, sternal wound infections, and cutaneous nocardiosis are less common presentations [1]. Adrenal abscesses due to nocardia have only been described in 8 case reports [4] and have only been previously reported twice as occurring in the bilateral adrenal glands [8, 9]. In contrast to the more common mode of entry of inhalation of bacteria causing pulmonary infection and dissemination, our patient presented with bacteremia, right-sided endocarditis, and negative CXR, suggesting that the mode of entry was direct hematologic spread through inoculation of the bacteria by nature of intravenous drug use. Treatment of nocardia adrenal abscess should include drainage and appropriate antibiotics, depending on sensitivity, including TMX-SMX, carpabenems, amikacin, minocycline, third-generation cephalosprins, and linezolid [3, 4, 10]. Meropenem was used specifically in this case because it is the formulary carbapenem at our institution.

CONCLUSION

Our case highlights the importance of considering the possibility of nocardia infection in IVDU, especially in the presence of other predisposing conditions. Nocardia should be included in the differential diagnosis of adrenal abscess in the aforementioned patient population as direct inoculation of the bacteria through the IVDU is likely. Early diagnosis and treatment improve prognosis.
  10 in total

1.  Laparoscopic drainage of nocardial adrenal abscess in an HIV positive patient.

Authors:  Yew Lam Chong; Justin Anton Green; Khai Lee Toh; James K Tan
Journal:  Int J Urol       Date:  2004-07       Impact factor: 3.369

2.  Systemic nocardiosis in a splenectomized patient with systemic lupus erythematosus: successful treatment using linezolid.

Authors:  Rupak K Moitra; Cressida Auckland; Michael I D Cawley; Graeme Jones; Cyrus Cooper
Journal:  J Clin Rheumatol       Date:  2003-02       Impact factor: 3.517

Review 3.  Nocardia infection in splenectomized patients: case reports and a review of the literature.

Authors:  E A Abdi; J C Ding; I A Cooper
Journal:  Postgrad Med J       Date:  1987-06       Impact factor: 2.401

Review 4.  [Nocardiosis in 2 immunocompetent patients].

Authors:  A Casas Vara; X Camino Ortiz de Barrón; M C Fernández Calvo; A Resano Igal; G Zubillaga Garmendia
Journal:  An Med Interna       Date:  2000-08

5.  Adrenal insufficiency, recurrent bacteremia, and disseminated abscesses caused by Nocardia asteroides in a patient with acquired immunodeficiency syndrome.

Authors:  Y Arabi; M R Fairfax; M J Szuba; L Crane; P Schuman
Journal:  Diagn Microbiol Infect Dis       Date:  1996-01       Impact factor: 2.803

Review 6.  Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy.

Authors:  Barbara A Brown-Elliott; June M Brown; Patricia S Conville; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

Review 7.  A case series and focused review of nocardiosis: clinical and microbiologic aspects.

Authors:  Edith R Lederman; Nancy F Crum
Journal:  Medicine (Baltimore)       Date:  2004-09       Impact factor: 1.889

8.  Disseminated systemic Nocardia farcinica infection complicating alefacept and infliximab therapy in a patient with severe psoriasis.

Authors:  Jaffar A Al-Tawfiq; Adil A Al-Khatti
Journal:  Int J Infect Dis       Date:  2009-06-05       Impact factor: 3.623

9.  Disseminated Nocardia Farcinica Pneumonia with Left Adrenal Gland Abscess.

Authors:  Christopher Jackson; Brennan McCullar; Kiran Joglekar; Ankur Seth; Hiren Pokharna
Journal:  Cureus       Date:  2017-04-12

Review 10.  Abscess of adrenal gland caused by disseminated subacute Nocardia farcinica pneumonia. A case report and mini-review of the literature.

Authors:  Michael Tachezy; Philipp Simon; Corina Ilchmann; Yogesh K Vashist; Jakob R Izbicki; Karim A Gawad
Journal:  BMC Infect Dis       Date:  2009-12-02       Impact factor: 3.090

  10 in total
  1 in total

1.  Cryptogenic Organizing Pneumonia Complicated With Cutaneous Disseminated Nocardia Infection: A Case Report and Literature Review.

Authors:  Zhijing Wei; Pengchen Bao; Tianle Wang; Wei Wang; Wen-Yang Li
Journal:  Front Med (Lausanne)       Date:  2022-06-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.